BeStock  
Stocks › CTKB

Cytek Biosciences CTKB

US equityMarket cap rank #3517
$5.34 −$0.04 (-0.74%)
Pre-market · Oct 8, 8:20 am ET · After hours $5.34 0.00%
Open$5.21
Prev close$5.38
Day range$5.11 – $5.34
Volume1.78M
Market cap$694.11M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.5x
CheapRich

Above its usual level · 73rd percentile, 5-year average -137.4x

Price / book2.2x
CheapRich

Around its usual level · 52nd percentile, 5-year average -1.9x

#3080 of 5317 stocks by PB (1 = cheapest)

Price / sales3.4x
CheapRich

Below its usual level · 31st percentile, 5-year average 6.8x

#3294 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-2,451x-685x1,082x2,849xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$7.59
Price vs. fair value-29.7%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.16 – -1.89 52% (pricier than usual) #3080 of 5317 (1 = cheapest)
PE -8.48 -19.15 -137.36 73% (pricier than usual) –
PS 3.36 3.20 6.80 31% (cheaper than usual) #3294 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$7.59
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on CTKB.

Leave a comment

Scroll to Top